{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:11:33Z","timestamp":1790323893949,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00520-026-11114-x","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:10:12Z","timestamp":1788192612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemotherapy-induced thrombocytopenia: from \u201cplatelet counting\u201d to ecological repair of the bone marrow"],"prefix":"10.1007","volume":"34","author":[{"given":"Tongkun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"11114_CR1","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.2147\/IJGM.S383349","volume":"15","author":"B Song","year":"2022","unstructured":"Song B, Zhou S, Li C et al (2022) A prediction model for chemotherapy-induced thrombocytopenia based on real-world data and a close relationship between AST\/ALT ratio and platelet count in patients with solid tumors. Int J Gen Med 15:8003\u20138015. https:\/\/doi.org\/10.2147\/IJGM.S383349","journal-title":"Int J Gen Med"},{"key":"11114_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/17474086.2023.2201428","volume":"16","author":"AB Song","year":"2023","unstructured":"Song AB, Al-Samkari H (2023) Emerging data on thrombopoietin receptor agonists for management of chemotherapy-induced thrombocytopenia. Expert Rev Hematol 16:365\u2013375. https:\/\/doi.org\/10.1080\/17474086.2023.2201428","journal-title":"Expert Rev Hematol"},{"key":"11114_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32080455","author":"S Peshin","year":"2025","unstructured":"Peshin S, Dharia A, Takrori E et al (2025) Understanding chemotherapy-induced thrombocytopenia: implications for gastrointestinal cancer treatment. Curr Oncol. https:\/\/doi.org\/10.3390\/curroncol32080455","journal-title":"Curr Oncol"},{"key":"11114_CR4","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2023.055","volume":"15","author":"G Falconi","year":"2023","unstructured":"Falconi G, Galossi E, Hajrullaj H et al (2023) Bone marrow microenvironment involvement in t-MN: focus on mesenchymal stem cells. Mediterr J Hematol Infect Dis 15:e2023055. https:\/\/doi.org\/10.4084\/MJHID.2023.055","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"11114_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ccr.2008.08.001","volume":"14","author":"Y Shaked","year":"2008","unstructured":"Shaked Y, Henke E, Roodhart JM et al (2008) Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 14:263\u201373. https:\/\/doi.org\/10.1016\/j.ccr.2008.08.001","journal-title":"Cancer Cell"},{"key":"11114_CR6","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1158\/0008-5472.CAN-06-4303","volume":"67","author":"A Zeuner","year":"2007","unstructured":"Zeuner A, Signore M, Martinetti D et al (2007) Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 67:4767\u201373. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4303","journal-title":"Cancer Res"},{"key":"11114_CR7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/bjh.19722","volume":"205","author":"H Chen","year":"2024","unstructured":"Chen H, Jiao Y, Lin C et al (2024) Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16\/akt signalling of haematological patients with chemotherapy-induced thrombocytopenia. Br J Haematol 205:1532\u20131545. https:\/\/doi.org\/10.1111\/bjh.19722","journal-title":"Br J Haematol"},{"key":"11114_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101139","volume":"63","author":"H Al-Samkari","year":"2024","unstructured":"Al-Samkari H (2024) Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists. Blood Rev 63:101139. https:\/\/doi.org\/10.1016\/j.blre.2023.101139","journal-title":"Blood Rev"},{"key":"11114_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3324\/haematol.2021.279512","volume":"107","author":"DJ Kuter","year":"2022","unstructured":"Kuter DJ (2022) Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies. Haematologica 107:1243\u20131263. https:\/\/doi.org\/10.3324\/haematol.2021.279512","journal-title":"Haematologica"},{"key":"11114_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1634688","volume":"16","author":"X Zhao","year":"2025","unstructured":"Zhao X, Shan X, Sui S et al (2025) Cancer treatment-induced thrombocytopenia: diagnosis, mechanisms and management. Front Immunol 16:1634688. https:\/\/doi.org\/10.3389\/fimmu.2025.1634688","journal-title":"Front Immunol"},{"key":"11114_CR11","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/S2352-3026(22)00001-1","volume":"9","author":"H Al-Samkari","year":"2022","unstructured":"Al-Samkari H, Kolb-Sielecki J, Safina SZ et al (2022) Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol 9:e179\u2013e189. https:\/\/doi.org\/10.1016\/S2352-3026(22)00001-1","journal-title":"Lancet Haematol"},{"key":"11114_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jtha.2023.09.031","volume":"22","author":"G Soff","year":"2024","unstructured":"Soff G, Leader A, Al-Samkari H et al (2024) Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH subcommittee on hemostasis and malignancy. J Thromb Haemost 22:53\u201360. https:\/\/doi.org\/10.1016\/j.jtha.2023.09.031","journal-title":"J Thromb Haemost"},{"key":"11114_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12957-025-03659-8","volume":"23","author":"H Hu","year":"2025","unstructured":"Hu H, Lei D, Liang Y (2025) Observation on the efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors. World J Surg Oncol 23:13. https:\/\/doi.org\/10.1186\/s12957-025-03659-8","journal-title":"World J Surg Oncol"},{"key":"11114_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2025.102980","volume":"9","author":"H Al-Samkari","year":"2025","unstructured":"Al-Samkari H (2025) Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia? Res Pr Thromb Haemost 9:102980. https:\/\/doi.org\/10.1016\/j.rpth.2025.102980","journal-title":"Res Pr Thromb Haemost"},{"key":"11114_CR15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/bjh.20037","volume":"206","author":"AB Song","year":"2025","unstructured":"Song AB, Al-Samkari H (2025) Chemotherapy-induced thrombocytopenia: modern diagnosis and treatment. Br J Haematol 206:1062\u20131066. https:\/\/doi.org\/10.1111\/bjh.20037","journal-title":"Br J Haematol"},{"key":"11114_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-021-00627-y","volume":"6","author":"HY Zhao","year":"2021","unstructured":"Zhao HY, Zhang YY, Xing T et al (2021) M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity. Signal Transduct Target Ther 6:234. https:\/\/doi.org\/10.1038\/s41392-021-00627-y","journal-title":"Signal Transduct Target Ther"},{"key":"11114_CR17","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00018-014-1813-y","volume":"72","author":"A Malara","year":"2015","unstructured":"Malara A, Abbonante V, Di Buduo CA et al (2015) The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control. Cell Mol Life Sci 72:1517\u201336. https:\/\/doi.org\/10.1007\/s00018-014-1813-y","journal-title":"Cell Mol Life Sci"},{"key":"11114_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3324\/haematol.2024.287236","volume":"110","author":"C Du","year":"2025","unstructured":"Du C, Chen J, Wang J (2025) New insights into the generation and function of megakaryocytes in health and disease. Haematologica 110:1500\u20131512. https:\/\/doi.org\/10.3324\/haematol.2024.287236","journal-title":"Haematologica"},{"key":"11114_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.stem.2015.07.007","volume":"17","author":"S Haas","year":"2015","unstructured":"Haas S, Hansson J, Klimmeck D et al (2015) Inflammation-induced emergency megakaryopoiesis driven by hematopoietic stem cell-like megakaryocyte progenitors. Cell Stem Cell 17:422\u2013434. https:\/\/doi.org\/10.1016\/j.stem.2015.07.007","journal-title":"Cell Stem Cell"},{"key":"11114_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116290","author":"YH Wu","year":"2022","unstructured":"Wu YH, Chen HY, Hong WC et al (2022) Carboplatin-induced thrombocytopenia through JAK2 downregulation, S-phase cell cycle arrest and apoptosis in megakaryocytes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116290","journal-title":"Int J Mol Sci"},{"key":"11114_CR21","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/jth.14544","volume":"17","author":"D Ghalloussi","year":"2019","unstructured":"Ghalloussi D, Dhenge A, Bergmeier W (2019) New insights into cytoskeletal remodeling during platelet production. J Thromb Haemost 17:1430\u20131439. https:\/\/doi.org\/10.1111\/jth.14544","journal-title":"J Thromb Haemost"},{"key":"11114_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114388","volume":"43","author":"CM Garyn","year":"2024","unstructured":"Garyn CM, Bover O, Murray JW et al (2024) G2 arrest primes hematopoietic stem cells for megakaryopoiesis. Cell Rep 43:114388. https:\/\/doi.org\/10.1016\/j.celrep.2024.114388","journal-title":"Cell Rep"},{"key":"11114_CR23","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1084\/jem.20110750","volume":"208","author":"EC Josefsson","year":"2011","unstructured":"Josefsson EC, James C, Henley KJ et al (2011) Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J Exp Med 208:2017\u20132031. https:\/\/doi.org\/10.1084\/jem.20110750","journal-title":"J Exp Med"},{"key":"11114_CR24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/ATVBAHA.119.312129","volume":"39","author":"LJ Noetzli","year":"2019","unstructured":"Noetzli LJ, French SL, Machlus KR (2019) New insights into the differentiation of megakaryocytes from hematopoietic progenitors. Arterioscler Thromb Vasc Biol 39:1288\u20131300. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312129","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"11114_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1182\/blood-2016-11-752840","volume":"130","author":"KR Machlus","year":"2017","unstructured":"Machlus KR, Wu SK, Vijey P et al (2017) Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis. Blood 130:1132\u20131143. https:\/\/doi.org\/10.1182\/blood-2016-11-752840","journal-title":"Blood"},{"key":"11114_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1055\/s-0040-1716530","volume":"121","author":"J Huang","year":"2021","unstructured":"Huang J, Huang S, Ma Z et al (2021) Ibrutinib suppresses early megakaryopoiesis but enhances proplatelet formation. Thromb Haemost 121:192\u2013205. https:\/\/doi.org\/10.1055\/s-0040-1716530","journal-title":"Thromb Haemost"},{"key":"11114_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/MOH.0000000000000451","volume":"25","author":"HG Roweth","year":"2018","unstructured":"Roweth HG, Parvin S, Machlus KR (2018) Megakaryocyte modification of platelets in thrombocytopenia. Curr Opin Hematol 25:410\u2013415. https:\/\/doi.org\/10.1097\/MOH.0000000000000451","journal-title":"Curr Opin Hematol"},{"key":"11114_CR28","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.jtha.2024.03.010","volume":"22","author":"L Chen","year":"2024","unstructured":"Chen L, Liu J, Chen K et al (2024) SET domain containing 2 promotes megakaryocyte polyploidization and platelet generation through methylation of alpha-tubulin. J Thromb Haemost 22:1727\u20131741. https:\/\/doi.org\/10.1016\/j.jtha.2024.03.010","journal-title":"J Thromb Haemost"},{"key":"11114_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101017","volume":"72","author":"S Ranjit","year":"2024","unstructured":"Ranjit S, Wang Y, Zhu J et al (2024) ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity. Drug Resist Updat 72:101017. https:\/\/doi.org\/10.1016\/j.drup.2023.101017","journal-title":"Drug Resist Updat"},{"key":"11114_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109102","volume":"35","author":"T Heib","year":"2021","unstructured":"Heib T, Hermanns HM, Manukjan G et al (2021) RhoA\/Cdc42 signaling drives cytoplasmic maturation but not endomitosis in megakaryocytes. Cell Rep 35:109102. https:\/\/doi.org\/10.1016\/j.celrep.2021.109102","journal-title":"Cell Rep"},{"key":"11114_CR31","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3324\/haematol.2018.196329","volume":"105","author":"T Rademakers","year":"2020","unstructured":"Rademakers T, Goedhart M, Hoogenboezem M et al (2020) Hematopoietic stem and progenitor cells use podosomes to transcellularly cross the bone marrow endothelium. Haematologica 105:2746\u20132756. https:\/\/doi.org\/10.3324\/haematol.2018.196329","journal-title":"Haematologica"},{"key":"11114_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1084\/jem.188.3.539","volume":"188","author":"T Hamada","year":"1998","unstructured":"Hamada T, Mohle R, Hesselgesser J et al (1998) Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 188:539\u2013548. https:\/\/doi.org\/10.1084\/jem.188.3.539","journal-title":"J Exp Med"},{"key":"11114_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm973","volume":"10","author":"ST Avecilla","year":"2004","unstructured":"Avecilla ST, Hattori K, Heissig B et al (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 10:64\u201371. https:\/\/doi.org\/10.1038\/nm973","journal-title":"Nat Med"},{"key":"11114_CR34","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1182\/bloodadvances.2022008680","volume":"7","author":"I Guinard","year":"2023","unstructured":"Guinard I, Nguyen T, Brassard-Jollive N et al (2023) Matrix stiffness controls megakaryocyte adhesion, fibronectin fibrillogenesis, and proplatelet formation through Itgbeta3. Blood Adv 7:4003\u20134018. https:\/\/doi.org\/10.1182\/bloodadvances.2022008680","journal-title":"Blood Adv"},{"key":"11114_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1083\/jcb.201410052","volume":"209","author":"S Nishimura","year":"2015","unstructured":"Nishimura S, Nagasaki M, Kunishima S et al (2015) IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 209:453\u2013466. https:\/\/doi.org\/10.1083\/jcb.201410052","journal-title":"J Cell Biol"},{"key":"11114_CR36","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.3324\/haematol.2016.161562","volume":"102","author":"V Abbonante","year":"2017","unstructured":"Abbonante V, Di Buduo CA, Gruppi C et al (2017) A new path to platelet production through matrix sensing. Haematologica 102:1150\u20131160. https:\/\/doi.org\/10.3324\/haematol.2016.161562","journal-title":"Haematologica"},{"key":"11114_CR37","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1182\/blood.2020005399","volume":"136","author":"K Golan","year":"2020","unstructured":"Golan K, Singh AK, Kollet O et al (2020) Bone marrow regeneration requires mitochondrial transfer from donor Cx43-expressing hematopoietic progenitors to stroma. Blood 136:2607\u20132619. https:\/\/doi.org\/10.1182\/blood.2020005399","journal-title":"Blood"},{"key":"11114_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI189801","author":"C Gao","year":"2025","unstructured":"Gao C, Dai Y, Spezza PA et al (2025) Megakaryocytes transfer mitochondria to bone marrow mesenchymal stromal cells to lower platelet activation. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI189801","journal-title":"J Clin Invest"},{"key":"11114_CR39","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1111\/jcmm.13809","volume":"22","author":"C Xie","year":"2018","unstructured":"Xie C, Zhao H, Bao X et al (2018) Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist. J Cell Mol Med 22:5367\u20135377. https:\/\/doi.org\/10.1111\/jcmm.13809","journal-title":"J Cell Mol Med"},{"key":"11114_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fendo.2017.00059","volume":"8","author":"LN Varghese","year":"2017","unstructured":"Varghese LN, Defour JP, Pecquet C, Constantinescu SN (2017) The thrombopoietin receptor: structural basis of traffic and activation by ligand, mutations, agonists, and mutated calreticulin. Front Endocrinol (Lausanne) 8:59. https:\/\/doi.org\/10.3389\/fendo.2017.00059","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11114_CR41","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3324\/haematol.2016.146746","volume":"101","author":"CA Di Buduo","year":"2016","unstructured":"Di Buduo CA, Currao M, Pecci A et al (2016) Revealing eltrombopag\u2019s promotion of human megakaryopoiesis through AKT\/ERK-dependent pathway activation. Haematologica 101:1479\u20131488. https:\/\/doi.org\/10.3324\/haematol.2016.146746","journal-title":"Haematologica"},{"key":"11114_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1538-7836.2009.03658.x","volume":"8","author":"S Severin","year":"2010","unstructured":"Severin S, Ghevaert C, Mazharian A (2010) The mitogen-activated protein kinase signaling pathways: role in megakaryocyte differentiation. J Thromb Haemost 8:17\u201326. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03658.x","journal-title":"J Thromb Haemost"},{"key":"11114_CR43","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.450","author":"P Scheinberg","year":"2018","unstructured":"Scheinberg P (2018) Activity of eltrombopag in severe aplastic anemia. Hematology. https:\/\/doi.org\/10.1182\/asheducation-2018.1.450","journal-title":"Hematology"},{"key":"11114_CR44","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/bjh.18332","volume":"198","author":"R Kapur","year":"2022","unstructured":"Kapur R (2022) Regulatory T cells are replenished in the splenic microenvironment of patients with immune thrombocytopenia by treatment with thrombopoietin receptor agonists. Br J Haematol 198:803\u2013804. https:\/\/doi.org\/10.1111\/bjh.18332","journal-title":"Br J Haematol"},{"key":"11114_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1182\/blood.2023022738","volume":"144","author":"L Wang","year":"2024","unstructured":"Wang L, Wang H, Zhu M et al (2024) Platelet-derived TGF-beta1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia. Blood 144:99\u2013112. https:\/\/doi.org\/10.1182\/blood.2023022738","journal-title":"Blood"},{"key":"11114_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/bjh.19074","volume":"203","author":"A Schifferli","year":"2023","unstructured":"Schifferli A, Rufer A, Rovo A et al (2023) Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: the iROM study. Br J Haematol 203:119\u2013130. https:\/\/doi.org\/10.1111\/bjh.19074","journal-title":"Br J Haematol"},{"key":"11114_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100158","volume":"7","author":"J Tilburg","year":"2023","unstructured":"Tilburg J, Stone AP, Billingsley JM et al (2023) Spatial transcriptomics of murine bone marrow megakaryocytes at single-cell resolution. Res Pract Thromb Haemost 7:100158. https:\/\/doi.org\/10.1016\/j.rpth.2023.100158","journal-title":"Res Pract Thromb Haemost"},{"key":"11114_CR48","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029769","author":"H Mei","year":"2025","unstructured":"Mei H, Xu M, Shu JJ et al (2025) Integrin alphavbeta8-mediated TGF-beta1 activation regulates sustained response in immune thrombocytopenia after TPO-RA withdrawal. Blood. https:\/\/doi.org\/10.1182\/blood.2025029769","journal-title":"Blood"},{"key":"11114_CR49","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/ajh.26338","volume":"96","author":"AB Song","year":"2021","unstructured":"Song AB, Goodarzi K, Karp Leaf R et al (2021) Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. Am J Hematol 96:1563\u20131568. https:\/\/doi.org\/10.1002\/ajh.26338","journal-title":"Am J Hematol"},{"key":"11114_CR50","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/ajh.25275","volume":"93","author":"H Al-Samkari","year":"2018","unstructured":"Al-Samkari H, Kuter DJ (2018) Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. Am J Hematol 93:1501\u20131508. https:\/\/doi.org\/10.1002\/ajh.25275","journal-title":"Am J Hematol"},{"key":"11114_CR51","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1056\/NEJMoa2511882","volume":"394","author":"H Al-Samkari","year":"2026","unstructured":"Al-Samkari H, Mu\u00f1oz C, Geredeli \u00c7 et al (2026) Romiplostim versus placebo for chemotherapy-induced thrombocytopenia. N Engl J Med 394:1061\u20131073. https:\/\/doi.org\/10.1056\/NEJMoa2511882","journal-title":"N Engl J Med"},{"key":"11114_CR52","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s40265-021-01553-7","volume":"81","author":"J Gilreath","year":"2021","unstructured":"Gilreath J, Lo M, Bubalo J (2021) Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists. Drugs 81:1285\u20131305. https:\/\/doi.org\/10.1007\/s40265-021-01553-7","journal-title":"Drugs"},{"key":"11114_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.840044","volume":"12","author":"E Khatib-Massalha","year":"2022","unstructured":"Khatib-Massalha E, Mendez-Ferrer S (2022) Megakaryocyte diversity in ontogeny, functions and cell-cell interactions. Front Oncol 12:840044. https:\/\/doi.org\/10.3389\/fonc.2022.840044","journal-title":"Front Oncol"},{"key":"11114_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.912060","volume":"12","author":"H Zhan","year":"2022","unstructured":"Zhan H, Kaushansky K (2022) Megakaryocytes as the regulator of the hematopoietic vascular niche. Front Oncol 12:912060. https:\/\/doi.org\/10.3389\/fonc.2022.912060","journal-title":"Front Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11114-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:51:40Z","timestamp":1790322700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11114-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["11114"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11114-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no relevant financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not reproduce previously published material requiring permission.","order":2,"name":"Ethics","label":"Permission to reproduce material from other sources","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"914"}}